EU OKs Danaher Acquisition of GE Healthcare's Biopharma Business

Date : 12/18/2019 @ 6:27PM
Source : Dow Jones News
Stock : General Electric Company (GE)
Quote : 11.86  -0.39 (-3.18%) @ 1:00AM
After Hours
Last Trade
Last $ 11.91 ▲ 0.05 (0.42%)

EU OKs Danaher Acquisition of GE Healthcare's Biopharma Business

Danaher (NYSE:DHR)
Historical Stock Chart

3 Months : From Nov 2019 to Feb 2020

Click Here for more Danaher Charts.
   By Giulia Petroni 
 

The European Union on Wednesday approved Danaher Corp.'s (DHR) acquisition of GE Healthcare Life Sciences' biopharma business, subject to conditions.

The European Commission said Danaher committed to sell businesses that posed competition concerns. The acquisition is conditional on Danaher's compliance.

In February, General Electric Co. (GE) agreed to sell the business to Danaher for about $21 billion.

Both Danaher and the GE Healthcare Life Sciences' biopharma business are active in the manufacturing of products and services used in bioprocessing industries and compete in other life-sciences areas.

 

Write to Giulia Petroni at giulia.petroni@wsj.com

 

(END) Dow Jones Newswires

December 18, 2019 13:12 ET (18:12 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest GE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.